Holzer Health System and Cleveland Clinic have announced a new formal affiliation between the Holzer Center for Cancer Care (HCCC) and Cleveland Clinic Cancer Center. This affiliation expands access to highly specialized cancer treatments, clinical resources, and clinical trials for patients in the southeastern Ohio and western West Virginia communities.
“This affiliation will provide advanced care options for our patients,” said Shane Maliszewski, MBA, service line director, Holzer Center for Cancer Care. “We look forward to working with Cleveland Clinic Cancer Center to expand our treatments and therapies, and provide advanced care for our patients.”
Cleveland Clinic Cancer Center, the top ranked cancer program in Ohio, according to US News & World Report, conducted an extensive review process of care and services provided by the Holzer Center for Cancer Care.
Benefits of this affiliation include a streamlined referral process, consultations for treatment options with Cleveland Clinic physicians, and opportunities for clinical trials not previously available.
“Our affiliation with Holzer Center for Cancer Care will provide access to second opinions for patients in southeast Ohio and western West Virginia,” said Alex A. Adjei, M.D., Ph.D., chairman of Taussig Cancer Institute, Cleveland Clinic Cancer Center. “We look forward to collaborating with Holzer oncologists to help provide more patients with advanced treatments and therapies.”
The team at Holzer has combined their expertise to provide a unified approach to optimal cancer treatment. “We are known to offer comprehensive cancer care with a friendly touch,” said Mike Canady, CEO of Holzer. “Through this affiliation, we will continue to offer the very best care options right here in our communities. Patients can look to Holzer first, knowing that we are working with the best experts in the field if advanced specialized care is needed.”